10 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma.

Shanghai Hengrui Pharmaceutical
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Shy Therapeutics
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

Kalvista Pharmaceuticals
Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

Bristol-Myers Squibb
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use

Amgen